ArticleACS physical chemistry Au2026
Coumarin-Based Hybrids: From Linear Photophysical Properties to Multiphoton Excitation Behavior.
Article in ACS physical chemistry Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coumarin-based derivatives are recognized as tunable photonic building blocks due to their strong light-matter interaction and relevance for both linear and nonlinear optical applications. This work presents an investigation of the linear optical properties and multiphoton excitation response of four derivatives coupled with benzothiazole and benzimidazole moieties. The compounds 7-diethylamino-coumarin-benzothiazole, 6-bromo-coumarin-benzothiazole, and 7-diethylamino-coumarin-benzimidazole exhibit nearly identical absorption maxima (∼423-428 nm) and emission peaks (∼485 nm), while displaying pronounced differences in molar absorptivity and ground to first excited-state transition dipole moment (μ
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.